Quintara Biosciences Acquires Laragen Sanger Sequencing Business from Transnetyx

Transnetyx Acquires Laragen

August 22, 2023

Biotechnology

Transnetyx, a Memphis-based provider of outsourced genetic services, has acquired Laragen, a sequencing and genetic services company in Culver City, California. The deal adds Sanger and next-generation sequencing (NGS) capabilities to Transnetyx's service portfolio to broaden its offerings for academic, government, and pharmaceutical research customers.

SeqOne Acquires Congenica

September 2, 2025

Software

SeqOne has acquired Congenica, a UK clinical genomics software company spun out of the Wellcome Sanger Institute, creating one of the largest pure‑play genomics software firms serving over 160 laboratories in 30+ countries. The combined business will integrate SeqOne's AI-driven NGS analysis platform with Congenica's clinical decision‑support tools to accelerate rare disease diagnoses and personalized cancer therapies while expanding SeqOne's UK presence.

Bruker Corporation Acquires NanoString Technologies Business

May 6, 2024

Medical Devices

Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.

Inscripta Acquires Infinome Biosciences and Sestina Bio

January 18, 2023

Biotechnology

Inscripta, a genome engineering company based in Pleasanton, California, has acquired synthetic biology firms Infinome Biosciences and Sestina Bio to accelerate its capabilities in sustainable biomanufacturing. The acquisitions integrate Infinome's GenoScaler strain-engineering platform and Sestina's data-driven scale-up strain design to advance Inscripta's commercialization of bio-manufactured products for industrial and consumer markets.

Quanterix Corporation Acquires Akoya Biosciences

July 8, 2025

Medical Devices

Quanterix Corporation has completed its acquisition of Akoya Biosciences, combining Quanterix's ultra‑sensitive blood biomarker detection platform with Akoya's spatial biology imaging and reagents. Under the amended merger agreement, Quanterix issued approximately 7.8 million shares and paid about $20 million in cash to Akoya equity holders; the combined business is expected to expand the company's served addressable market and accelerate the path to profitability.

AbCellera Acquires TetraGenetics

September 13, 2021

Biotechnology

AbCellera Biologics Inc. acquired TetraGenetics, Inc. in an all-cash transaction to integrate TetraGenetics' recombinant transmembrane protein expression platform into AbCellera's antibody discovery technology stack. The acquisition expands AbCellera's ability to generate antibodies against difficult-to-drug ion channels, GPCRs and other transmembrane targets, and includes upfront and milestone-based payments.